Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00639769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: cisplatin
DRUG: irinotecan hydrochloride

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]